Effects of Skin-to-Skin Care on Premature Infants
Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study
This study tests if regular skin-to-skin care for premature babies can help them get more of their mother's milk and reduce health problems before they go home from the hospital.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 1 Day and up |
| Sex | All |
| Sponsor | Baskent University Ankara Hospital Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06672913 on ClinicalTrials.gov |
What this trial studies
This multicenter clinical study investigates the impact of standardized skin-to-skin care on clinical outcomes for infants born at or below 32 weeks of gestation. The study aims to evaluate the rate of receiving exclusive mothers' milk at discharge and assess the incidence of neonatal complications such as sepsis and necrotizing enterocolitis. Conducted in multiple hospitals, the research emphasizes the importance of early and regular skin-to-skin contact in the neonatal intensive care unit (NICU) to improve health outcomes for preterm infants. The study is led by the Turkish Neonatal Society and involves collaboration with several universities.
Who should consider this trial
Good fit: Ideal candidates for this study are infants born at or below 32 weeks of gestation.
Not a fit: Patients who may not benefit include those who die before NICU discharge or have abdominal wall defects.
Why it matters
Potential benefit: If successful, this approach could significantly improve breastfeeding rates and reduce complications in premature infants.
How similar studies have performed: Previous studies have shown positive outcomes with skin-to-skin care in neonatal settings, supporting the potential effectiveness of this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Infants born at gestational age ≤ 32 weeks Exclusion Criteria: * Death before NICU discharge * Abdominal wall defects
Where this trial is running
Ankara
- Baskent University — Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Sezin Unal, Prof, MD
- Email: sezinunal@gmail.com
- Phone: 00905324008018
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.